All Points of the Pharma Compass

All Points of the Pharma Compass

By The Pharma NavigatorScienceLife Sciences
Download on the App Store

All Points of the Pharma Compass episodes

  • Bridging the Solubility Barrier with Bile Acids

    As poor solubility continues to plague development pipelines, alternative biocompatible permeation enhancers are becoming increasingly beneficial for formulation scientists notes Roger Viney from ICE Pharma.


    Music from #Uppbeat (free for Creators!):

    https://uppbeat.io/t/roo-walker/over-the-horizon

    License code: 5NO64EK1IOM2OHMH

    12 min
  • Putting Clinical Trials Under a Magnifying Glass

    Marking Clinical Trial Awareness Day, Treehill Partners’ CEO Ali Pashazadeh details the flaws in clinical study designs and explains how high-velocity competition from Eastern markets is forcing a long-overdue industry redesign.


    Music from #Uppbeat (free for Creators!):

    uppbeat.io/t/roo-walker/over-the-horizon

    License code: DF1V6OVKVEQSFIAI

    32 min
  • ATMPs: At the Precipice of Success or Failure

    With major therapeutic indications close on the horizon, the industry must urgently address the prohibitive costs and manufacturing complexities currently blocking patient access to life-changing cures.

    Credit:

    Music from #Uppbeat (free for Creators!):

    https://uppbeat.io/t/roo-walker/over-the-horizon

    License code: JDOYSHIQBT8JRFSV

    30 min
  • Measuring More of What Matters

    Technological innovations are allowing for improvements in the clinical trial sector and providing greater volumes of data; however, companies should be mindful to ensure they are measuring meaningful data. In this latest episode of All Points of the Pharma Compass, we chat with Mikesh Udani from Albus Health to find out more about the innovations shaping the clinical trials sector.


    Music from #Uppbeat (free for Creators!):

    uppbeat.io/t/roo-walker/over-the-horizon

    License code: G3VNPEBBOP2ZU1CF

    16 min
  • Innovating Inhalation: The Future of Pulmonary and Nasal Drug Delivery

    Non-invasive drug delivery via pulmonary and nasal routes is increasingly in demand; however, while there has already been significant innovation within the sector, even more is required to meet future needs.


    Music from #Uppbeat (free for Creators!):

    uppbeat.io/t/roo-walker/over-the-horizon

    License code: SEVYSTJFQJ4MEGXU

    34 min
  • Staying Ahead in a Dynamic Market Environment

    In a review of CPHI Frankfurt 2025, several event exhibitors chat about the trends making waves in the industry and highlight the importance of face-to-face collaborations and networking.


    Music from #Uppbeat (free for Creators!):

    uppbeat.io/t/roo-walker/over-the-horizon

    License code: XQ4BQIXL56OESJJQ

    17 min

About All Points of the Pharma Compass

From the publisher's feed

Welcome to All Points of the Pharma Compass, the podcast from The Pharma Navigator that guides you through the most pressing industry issues.